Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG ("Araris") today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) ...
Researchers from the University at Buffalo and Roswell Park Comprehensive Cancer Center are developing an artificial ...
The Flow 2 sits firmly at that premium end, pitched as Narwal's 2026 flagship with a Vision Language Model, a heated track ...
Leaf veins stripped of soft tissue can serve as ready-made scaffolds for transparent electrodes and compostable circuit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results